Home Business Pfizer compra Global Blood Therapeutics, deal da 5,4 mld$

Pfizer compra Global Blood Therapeutics, deal da 5,4 mld$

by admin

M&A transaction for Pfizer. The big pharma USA has announced that it has reached a definitive agreement to take over the biopharmaceutical company Global Blood Therapeutics. Under the terms of the acquisition, Pfizer will put $ 68.5 per share on the plate, for a total enterprise value of approximately $ 5.4 billion (including debt and net of acquired cash). Both boards of the companies approved the transaction.

See also  Confcommercio: only 22% of Italian GDP is created in the South. In 1995 it was 24

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy